FDA alerts health care professionals of risks to patients exposed to xylazine in illicit drugs

Healthcare professionals have been alerted by the FDA to the dangers of patients being exposed to xylazine, a veterinary sedative, in illicit drugs. The FDA advises healthcare professionals to report any adverse events related to xylazine.

FDA alerts health care professionals of risks to patients exposed to xylazine in illicit drugs Read More »